Global Autorefractor market size is expected to reach $2.95 billion by 2029 at 11.2%, segmented as by manual autorefractor, tabletop manual autorefractor, handheld manual autorefractor, manual autorefractor with retinoscope
Read More
Global Autism Spectrum Disorder Diagnostics market size is expected to reach $38.94 billion by 2029 at 7.2%, segmented as by autistic disorder, classic autism, severe autism, mild autism
Read More
Global Atrial Septal Defect market size is expected to reach $6.03 billion by 2029 at 7.7%, segmented as by surgical closure, open heart surgery (traditional surgical closure), minimally invasive surgical closure, patches (pericardial
Read More
Global Atorvastatin market size is expected to reach $19.57 billion by 2029 at 10.5%, segmented as by chemical synthesis, traditional chemical synthesis of atorvastatin, semi-synthetic atorvastatin production
Read More
Global Atenolol market size is expected to reach $17.16 billion by 2029 at 8.3%, segmented as by 98% purity, atenolol with 98% purity for pharmaceutical formulations, atenolol 98% purity for generic drug production
Read More
Global Assisted Living Technologies market size is expected to reach $16.74 billion by 2029 at 16.4%, segmented as by hardware, wearable devices (smartwatches, health trackers), sensors (motion, pressure, temperature)
Read More
Global Assisted Living Facility And Neurorehabilitation market size is expected to reach $69.74 billion by 2029 at 7.8%, segmented as by women, elderly women, women with cognitive disorders, women with physical disabilities
Read More
Global Aseptic Sampling market size is expected to reach $1.5 billion by 2029 at 11.3%, segmented as by manual aseptic sampling, single-use manual sampling, reusable manual sampling
Read More
Global Artificial Saliva market size is expected to reach $3.72 billion by 2029 at 13.7%, segmented as by oral spray, non-alcoholic oral spray, alcohol-based oral spray
Read More
Global Artificial Pancreas Device System market size is expected to reach $3.48 billion by 2029 at 13.9%, segmented as by threshold suspend device systems, insulin pump with threshold suspend, continuous glucose monitoring (cgm) integrated systems
Read More